Association of plasma beta-amyloid level and cognitive reserve with subsequent cognitive decline
- PMID: 21245181
- PMCID: PMC3108075
- DOI: 10.1001/jama.2010.1995
Association of plasma beta-amyloid level and cognitive reserve with subsequent cognitive decline
Abstract
Context: Lower plasma β-amyloid 42 and 42/40 levels have been associated with incident dementia, but results are conflicting and few have investigated cognitive decline among elders without dementia.
Objective: To determine if plasma β-amyloid is associated with cognitive decline and if this association is modified by measures of cognitive reserve.
Design, setting, and participants: We studied 997 black and white community-dwelling older adults from Memphis, Tennessee, and Pittsburgh, Pennsylvania, who were enrolled in the Health ABC Study, a prospective observational study begun in 1997-1998 with 10-year follow-up in 2006-2007. Participant mean age was 74.0 (SD, 3.0) years; 55.2% (n = 550) were female; and 54.0% (n = 538) were black.
Main outcome measures: Association of near-baseline plasma β-amyloid levels (42 and 42/40 measured in 2010) and repeatedly measured Modified Mini-Mental State Examination (3MS) results.
Results: Low β-amyloid 42/40 level was associated with greater 9-year 3MS cognitive decline (lowest β-amyloid tertile: mean change in 3MS score, -6.59 [95% confidence interval [CI], -5.21 to -7.67] points; middle tertile: -6.16 [95% CI, -4.92 to -7.32] points; and highest tertile: -3.60 [95% CI, -2.27 to -4.73] points; P < .001). Results were similar after multivariate adjustment for age, race, education, diabetes, smoking, and apolipoprotein E [APOE ] e4 status and after excluding the 72 participants with incident dementia. Measures of cognitive reserve modified this association whereby among those with high reserve (at least a high school diploma, higher than sixth-grade literacy, or no APOE e4 allele), β-amyloid 42/40 was less associated with multivariate adjusted 9-year decline. For example, among participants with less than a high school diploma, the 3MS score decline was -8.94 (95% CI, -6.94 to -10.94) for the lowest tertile compared with -4.45 (95% CI, -2.31 to -6.59) for the highest tertile, but for those with at least a high school diploma, 3MS score decline was -4.60 (95% CI,-3.07 to -6.13) for the lowest tertile and -2.88 (95% CI,-1.41 to -4.35) for the highest tertile (P = .004 for interaction). Interactions were also observed for literacy (P = .005) and for APOE e4 allele (P = .02).
Conclusion: Lower plasma β-amyloid 42/40 is associated with greater cognitive decline among elderly persons without dementia over 9 years, and this association is stronger among those with low measures of cognitive reserve.
Figures
Comment in
-
Mapping out biomarkers for Alzheimer disease.JAMA. 2011 Jan 19;305(3):304-5. doi: 10.1001/jama.2010.2017. JAMA. 2011. PMID: 21245188 No abstract available.
-
Lower plasma β-amyloid levels are associated with moderately greater rate of cognitive decline among older people without dementia.Evid Based Ment Health. 2011 May;14(2):41. doi: 10.1136/ebmh.14.2.41. Evid Based Ment Health. 2011. PMID: 21502147 No abstract available.
-
Plasma beta-amyloid level, cognitive reserve, and cognitive decline.JAMA. 2011 Apr 27;305(16):1655; author reply 1655-6. doi: 10.1001/jama.2011.525. JAMA. 2011. PMID: 21521842 No abstract available.
-
Plasma beta-amyloid level, cognitive reserve, and cognitive decline.JAMA. 2011 Apr 27;305(16):1655; author reply 1655-6. doi: 10.1001/jama.2011.524. JAMA. 2011. PMID: 21521843 No abstract available.
-
Plasma beta-amyloid linked to cognitive decline.Arch Neurol. 2011 Jun;68(6):799-801. doi: 10.1001/archneurol.2011.114. Arch Neurol. 2011. PMID: 21670404 No abstract available.
Similar articles
-
Plasma beta amyloid level and depression in older adults.J Gerontol A Biol Sci Med Sci. 2013 Jan;68(1):74-9. doi: 10.1093/gerona/gls093. Epub 2012 Apr 12. J Gerontol A Biol Sci Med Sci. 2013. PMID: 22499763 Free PMC article.
-
Association of Plasma Amyloid-β and Dementia Among Black and White Older Adults.J Alzheimers Dis. 2024;99(2):787-797. doi: 10.3233/JAD-240007. J Alzheimers Dis. 2024. PMID: 38701147
-
Cognitive resilience to apolipoprotein E ε4: contributing factors in black and white older adults.JAMA Neurol. 2015 Mar;72(3):340-8. doi: 10.1001/jamaneurol.2014.3978. JAMA Neurol. 2015. PMID: 25599330 Free PMC article.
-
Assessment of Plasma Amyloid-β42/40 and Cognitive Decline Among Community-Dwelling Older Adults.JAMA Netw Open. 2020 Dec 1;3(12):e2028634. doi: 10.1001/jamanetworkopen.2020.28634. JAMA Netw Open. 2020. PMID: 33331917 Free PMC article. Clinical Trial.
-
Plasma and cerebrospinal fluid amyloid beta for the diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI).Cochrane Database Syst Rev. 2014 Jun 10;2014(6):CD008782. doi: 10.1002/14651858.CD008782.pub4. Cochrane Database Syst Rev. 2014. PMID: 24913723 Free PMC article. Review.
Cited by
-
Androgen deprivation therapy exacerbates Alzheimer's-associated cognitive decline via increased brain immune cell infiltration.Sci Adv. 2024 Jun 21;10(25):eadn8709. doi: 10.1126/sciadv.adn8709. Epub 2024 Jun 21. Sci Adv. 2024. PMID: 38905345 Free PMC article.
-
Role of vitamin B12 and folic acid in treatment of Alzheimer's disease: a meta-analysis of randomized control trials.Aging (Albany NY). 2024 May 2;16(9):7856-7869. doi: 10.18632/aging.205788. Epub 2024 May 2. Aging (Albany NY). 2024. PMID: 38700503 Free PMC article.
-
Associations Between Blood-Based Biomarkers and Cognitive and Functional Trajectories Among Participants of the MEMENTO Cohort.Neurology. 2024 May;102(9):e209307. doi: 10.1212/WNL.0000000000209307. Epub 2024 Apr 16. Neurology. 2024. PMID: 38626384 Free PMC article.
-
Blood-based biomarkers for Alzheimer's disease and cognitive function from mid- to late life.Alzheimers Dement. 2024 Mar;20(3):1807-1814. doi: 10.1002/alz.13583. Epub 2023 Dec 21. Alzheimers Dement. 2024. PMID: 38126555 Free PMC article.
-
Folate Deficiency Increased Microglial Amyloid-β Phagocytosis via the RAGE Receptor in Chronic Unpredictable Mild-Stress Rat and BV2 Cells.Nutrients. 2023 Aug 8;15(16):3501. doi: 10.3390/nu15163501. Nutrients. 2023. PMID: 37630692 Free PMC article.
References
-
- Prince M, Jackson J. World Alzheimer Report. Alzheimer's Disease International. London. 2009
-
- Graff-Radford NR, Crook JE, Lucas J, et al. Association of low plasma Aβ42/Aβ40 ratios with increased imminent risk for mild cognitive impairment and Alzheimer disease. Arch Neurol. 2007;64:354–362. - PubMed
-
- Lewczuk P, Kornhuber J, Vanmechelen E, et al. Amyloid β peptides in plasma in early diagnosis of Alzheimer's disease: A multicenter study with multiplexing. Experimental Neurology. 2009 Aug 5; [Epub Ahead of Print] - PubMed
-
- Pesaresi M, Lovati C, Bertora P, et al. Plasma levels of beta-amyloid (1–42) in Alzheimer's disease and mild cognitive impairment. Neurobiol Aging. 2006;27:904–905. - PubMed
-
- Fukumoto H, Tennis M, Locascio JJ, Hyman BT, Growdon JH, Irizarry MC. Age but no diagnosis is the main predictor of plasma amyloid beta-protein levels. Arch Neurol. 2003;60:958–964. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous
